Back to Results
First PageMeta Content
Stem cells / Emerging technologies / Cell biology / Tendinosis / Regenerative medicine / Stem cell / Embryonic stem cell / Tendon / Baldness / Biology / Biotechnology / Developmental biology


NEWS RELEASE FOR IMMEDIATE RELEASE RepliCel Life Sciences Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium
Add to Reading List

Document Date: 2014-11-24 14:35:08

Open Document

File Size: 105,69 KB

Share Result on Facebook

City

VANCOUVER / Toronto / /

Company

RepliCel Life Sciences Inc. / TSX Venture Exchange / Government of Canada’s Networks / RepliCel Life Sciences RepliCel / Shiseido Company Limited / /

Country

Japan / Canada / China / South Korea / /

/

Event

Product Issues / /

Facility

University of Toronto / /

IndustryTerm

exemplary network / pipeline products / marketable products / cell manufacturing / regulatory services / biotechnology industry / secondary manufacturing site / contract regulatory services / ultra-sound imaging / technology transfer / /

MedicalCondition

chronic tendinosis / injury / chronic Achilles tendinosis / pain / diseases / skin and pattern baldness / degenerative disease / patellar tendinosis / pattern baldness / lateral elbow tendinosis / /

Organization

Regenerative Medicine / Centre for Commercialization of Regenerative Medicine / NEWS RELEASE FOR IMMEDIATE RELEASE RepliCel Life Sciences Joins Centre for Commercialization of Regenerative Medicine / Government of Canada / Centre for NEWS RELEASE Commercialization of Regenerative Medicine / University of Toronto / /

Person

David Hall / Michael May / Tammey George / Christina Cameron / Stacey Johnson / /

/

Position

CEO / President and CEO / Director of Communications / /

Product

pattern baldness / skin / /

ProvinceOrState

British Columbia / /

Technology

biotechnology / biomaterials / biomaterials-based technologies / Regenerative Medicine / /

URL

www.replicel.com / www.ccrm.ca / http /

SocialTag